0000719135-23-000036.txt : 20230628
0000719135-23-000036.hdr.sgml : 20230628
20230628140129
ACCESSION NUMBER: 0000719135-23-000036
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230626
FILED AS OF DATE: 20230628
DATE AS OF CHANGE: 20230628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hornsby Todd
CENTRAL INDEX KEY: 0001764505
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31885
FILM NUMBER: 231051193
MAIL ADDRESS:
STREET 1: 14321 HAWTHORNE DR.
CITY: CARMEL
STATE: IN
ZIP: 46033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apyx Medical Corp
CENTRAL INDEX KEY: 0000719135
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 112644611
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5115 ULMERTON ROAD
CITY: CLEARWATER
STATE: FL
ZIP: 33760
BUSINESS PHONE: 7273842323
MAIL ADDRESS:
STREET 1: 5115 ULMERTON ROAD
CITY: CLEARWATER
STATE: FL
ZIP: 33760
FORMER COMPANY:
FORMER CONFORMED NAME: BOVIE MEDICAL Corp
DATE OF NAME CHANGE: 20150319
FORMER COMPANY:
FORMER CONFORMED NAME: BOVIE MEDICAL CORP
DATE OF NAME CHANGE: 19990216
FORMER COMPANY:
FORMER CONFORMED NAME: AN CON GENETICS INC
DATE OF NAME CHANGE: 19920703
4
1
wk-form4_1687975277.xml
FORM 4
X0407
4
2023-06-26
0
0000719135
Apyx Medical Corp
APYX
0001764505
Hornsby Todd
C/O APYX MEDICAL CORPORATION
5115 ULMERTON ROAD
CLEARWATER
FL
33760
0
1
0
0
Executive Vice President
1
Common Stock
2023-06-26
4
M
0
15000
1.77
A
15000
D
Common Stock
2023-06-26
4
S
0
15000
7.56
D
40
D
Stock Option (Option to Buy)
1.77
2023-06-26
4
M
0
15000
0
D
2019-12-18
2025-12-17
Common Stock
15000
0
D
The reported sale occurred automatically pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on March 21, 2023.
This transaction was executed in multiple trades at prices ranging from $7.30 to $7.70. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Todd Hornsby
2023-06-28